#IPULSE TENS REVIEW SKIN#

This study also aims to examine patient use of the HFIT device versus the sham device.

We hypothesize that the cohort randomized to use the HFIT device will have a clinically significant increase in function and a clinically significant decrease in back pain compared to the sham group. This study describes a pilot study using an HFIT device (Enso, San Francisco, CA) in order to evaluate the impact on pain reduction and increase in function among patients with CLBP. Studies have also demonstrated that high frequency electrical stimulation can affect the firing of action potentials.

#IPULSE TENS REVIEW SKIN#

8–10 The ultra-high frequency system, known as high-frequency impulse therapy (HFIT), involves using specific waveforms in the 30–150 kHz range to both overcome the resistance of the skin and to deliver a higher frequency than TENS. Studies have demonstrated that high-frequency forms of electrical stimulation (10 kHz and greater frequencies) are effective for the treatment of chronic and acute pain and are thought to be due to the different mechanism of action of high-frequency neuromodulation. 7 Methods to overcome the capacitance of the skin structures include higher energy delivery (increased current or intensity) or higher voltage in order to charge the skin structures, such that subsequent field charges may pass through the skin. 6 A significant limitation for TENS is the ability to deliver adequate and precise electrical fields through the skin, which acts as a resistor. Studies have determined that while TENS can be effective for temporary treatment of musculoskeletal pain, it has not been demonstrated to be effective for long-term treatment of chronic musculoskeletal pain. Transcutaneous electrical nerve stimulation (TENS) is a form of electrical stimulation therapy used by pain physicians and physiotherapists to treat both chronic and acute forms of musculoskeletal pain. As a result, there continues to be a great need for an effective, drug-free, non-implanted treatment for CLBP. 5 While these technologies have improved options for pain control, they require surgical implantation, which increases risks to patients and costs to payors. Newer treatments in neuromodulation for refractory CLBP include novel devices in spinal cord and peripheral nerve stimulation. 3 Exercise therapy is a commonly used and moderately effective approach for managing CLBP 4 however, it may take several weeks to experience pain relief. 2 Approximately 51% of patients who live with back pain are unable to tolerate pharmacological pain treatments due to such side effects. 1 Existing pharmaceutical treatments, such as opioids, can be effective solutions to CBLP, but tend to cause side effects, including sedation, nausea, constipation and respiratory depression. Chronic low back pain (CLBP) poses significant morbidity for patients, affecting over 76 million people in the United States with total costs related to low back pain (LBP) exceeding $100 billion per year.

Ipulse tens review